Literature DB >> 15741761

Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study.

Vicente Balanzá-Martínez1, Rafael Tabarés-Seisdedos, Gabriel Selva-Vera, Anabel Martínez-Arán, Carla Torrent, José Salazar-Fraile, Carmen Leal-Cercós, Eduard Vieta, Manuel Gómez-Beneyto.   

Abstract

BACKGROUND: Neurocognitive impairment has consistently been considered a central and stable feature in schizophrenia. As this possibility has been far less studied in bipolar disorder, we aimed to prospectively investigate the stability and specificity of cognitive performance in bipolar disorder compared to schizophrenia.
METHODS: Fifteen DSM-IV bipolar type I patients and 15 schizophrenic patients were assessed twice with a comprehensive neuropsychological battery and the Positive and Negative Syndrome Scale over a 3-year follow-up. The cognitive performance of the groups was compared at baseline and 3 years later as a mean with that of 26 healthy volunteers. Endpoint and baseline assessments were also compared for each patient group in order to evaluate the stability of cognitive impairment.
RESULTS: At both time points, bipolar and schizophrenic patients showed significant deficits on most of the cognitive tasks compared to healthy subjects. Overall, the cross-sectional cognitive profile was similar for both patient groups. Moreover, after controlling for age and length of illness, the two groups' cognitive function did not differ over time in any test. With the exception of the Stroop color-word interference task, performance at baseline for each test but neither length of illness nor diagnostic category predicted the endpoint performance.
CONCLUSION: This preliminary study suggests that cognitive impairment is also mainly stable over time in bipolar I disorder and thus not specific to schizophrenia. 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15741761     DOI: 10.1159/000083170

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  27 in total

1.  Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.

Authors:  Tessa Christodoulou; Lambros Messinis; Panagiotis Papathanasopoulos; Sophia Frangou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-22       Impact factor: 5.270

Review 2.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

3.  Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up.

Authors:  Kathryn E Lewandowski; Bruce M Cohen; Matcheri S Keshavan; Sarah H Sperry; Dost Ongür
Journal:  Schizophr Res       Date:  2013-06-19       Impact factor: 4.939

4.  Clinical implications of cognitive function in bipolar disorder.

Authors:  C T Sudhir Kumar; Sophia Frangou
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

Review 5.  Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond.

Authors:  Emre Bora; Murat Yücel; Christos Pantelis
Journal:  Schizophr Bull       Date:  2009-09-23       Impact factor: 9.306

6.  Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years.

Authors:  Kelly A Ryan; Shervin Assari; Kaley Angers; David F Marshall; Kristin Hinrichs; Rebecca Easter; Pallavi Babu; Bethany D Pester; Scott A Langenecker; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2017-09-14       Impact factor: 6.744

7.  The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Authors:  Gabriel Selva-Vera; Vicent Balanzá-Martínez; José Salazar-Fraile; José Sánchez-Moreno; Anabel Martinez-Aran; Patricia Correa; Eduard Vieta; Rafael Tabarés-Seisdedos
Journal:  BMC Psychiatry       Date:  2010-06-15       Impact factor: 3.630

Review 8.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

9.  The longitudinal course of cognition in older adults with bipolar disorder.

Authors:  Ariel G Gildengers; Benoit H Mulsant; Amy Begley; Sati Mazumdar; Adriana V Hyams; Charles F Reynolds Iii; David J Kupfer; Meryl A Butters
Journal:  Bipolar Disord       Date:  2009-08-28       Impact factor: 6.744

10.  A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

Authors:  S Kristian Hill; James L Reilly; Margret S H Harris; Cherise Rosen; Robert W Marvin; Ovidio Deleon; John A Sweeney
Journal:  Schizophr Res       Date:  2009-05-17       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.